ZA200902155B - IPV-DPT vaccine - Google Patents
IPV-DPT vaccineInfo
- Publication number
- ZA200902155B ZA200902155B ZA200902155A ZA200902155A ZA200902155B ZA 200902155 B ZA200902155 B ZA 200902155B ZA 200902155 A ZA200902155 A ZA 200902155A ZA 200902155 A ZA200902155 A ZA 200902155A ZA 200902155 B ZA200902155 B ZA 200902155B
- Authority
- ZA
- South Africa
- Prior art keywords
- ipv
- dpt vaccine
- dpt
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32361—Methods of inactivation or attenuation
- C12N2770/32363—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006267439 | 2006-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200902155B true ZA200902155B (en) | 2010-06-30 |
Family
ID=39282813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200902155A ZA200902155B (en) | 2006-09-29 | 2007-09-28 | IPV-DPT vaccine |
Country Status (15)
Country | Link |
---|---|
US (1) | US8753646B2 (xx) |
EP (1) | EP2075005B1 (xx) |
JP (2) | JP4874339B2 (xx) |
KR (2) | KR20150080643A (xx) |
CN (3) | CN101522209A (xx) |
AU (1) | AU2007305595C1 (xx) |
BR (1) | BRPI0717145A2 (xx) |
CA (1) | CA2664799C (xx) |
ES (1) | ES2560452T3 (xx) |
HK (1) | HK1129836A1 (xx) |
MX (1) | MX2009002909A (xx) |
NZ (1) | NZ574776A (xx) |
RU (1) | RU2447898C2 (xx) |
WO (1) | WO2008044611A1 (xx) |
ZA (1) | ZA200902155B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
GB0822633D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
EP3459562B1 (en) | 2011-01-05 | 2024-03-20 | Bharat Biotech International Limited | A combination heptavalent vaccine |
CN102178949A (zh) * | 2011-05-13 | 2011-09-14 | 中国医学科学院医学生物学研究所 | 吸附无细胞百白破-Sabin株脊髓灰质炎联合疫苗及其制备 |
WO2017059449A1 (en) | 2015-10-02 | 2017-04-06 | Baylor College Of Medicine | Cultivation of human noroviruses |
GB2619625B (en) | 2019-05-20 | 2024-04-03 | Soligenix Inc | Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525349A (en) * | 1981-12-29 | 1985-06-25 | Societe Anonyme Dite: Institut Merueux | Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine |
US6696065B1 (en) * | 1995-05-04 | 2004-02-24 | Aventis Pastuer Limited | Acellular pertussis vaccines and methods of preparation thereof |
SK283565B6 (sk) * | 1996-07-02 | 2003-09-11 | Connaught Laboratories Limited | Multivalentná imunogénna kompozícia a jej použitie |
EP1793852A1 (en) | 2004-08-27 | 2007-06-13 | Panacea Biotec Ltd. | Inactivated poliomyelitis vaccine derived from sabin strain of polio virus |
CN1297313C (zh) * | 2004-09-16 | 2007-01-31 | 中国医学科学院医学生物学研究所 | 减毒株脊髓灰质炎灭活疫苗后处理方法 |
PL2066344T3 (pl) | 2006-09-07 | 2011-10-31 | Glaxosmithkline Biologicals Sa | Skojarzona szczepionka zawierająca inaktywowany wirus polio |
-
2007
- 2007-09-28 KR KR1020157016625A patent/KR20150080643A/ko not_active Application Discontinuation
- 2007-09-28 EP EP07829247.1A patent/EP2075005B1/en active Active
- 2007-09-28 MX MX2009002909A patent/MX2009002909A/es active IP Right Grant
- 2007-09-28 BR BRPI0717145-5A patent/BRPI0717145A2/pt not_active IP Right Cessation
- 2007-09-28 KR KR1020097007730A patent/KR101617464B1/ko active IP Right Grant
- 2007-09-28 ES ES07829247.1T patent/ES2560452T3/es active Active
- 2007-09-28 RU RU2009116273/15A patent/RU2447898C2/ru active
- 2007-09-28 AU AU2007305595A patent/AU2007305595C1/en not_active Ceased
- 2007-09-28 WO PCT/JP2007/069509 patent/WO2008044611A1/ja active Application Filing
- 2007-09-28 US US12/311,365 patent/US8753646B2/en not_active Expired - Fee Related
- 2007-09-28 CN CNA2007800362477A patent/CN101522209A/zh active Pending
- 2007-09-28 CN CN2013100910144A patent/CN103223163A/zh active Pending
- 2007-09-28 CA CA2664799A patent/CA2664799C/en not_active Expired - Fee Related
- 2007-09-28 CN CN201510553022.5A patent/CN105126095A/zh active Pending
- 2007-09-28 JP JP2008538693A patent/JP4874339B2/ja active Active
- 2007-09-28 ZA ZA200902155A patent/ZA200902155B/xx unknown
- 2007-09-28 NZ NZ574776A patent/NZ574776A/en not_active IP Right Cessation
-
2009
- 2009-08-06 HK HK09107222.6A patent/HK1129836A1/zh not_active IP Right Cessation
-
2011
- 2011-06-06 JP JP2011126139A patent/JP2011201913A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BRPI0717145A2 (pt) | 2013-11-12 |
ES2560452T3 (es) | 2016-02-19 |
RU2009116273A (ru) | 2010-11-10 |
RU2447898C2 (ru) | 2012-04-20 |
JPWO2008044611A1 (ja) | 2010-02-12 |
CN105126095A (zh) | 2015-12-09 |
MX2009002909A (es) | 2009-03-31 |
JP2011201913A (ja) | 2011-10-13 |
CN101522209A (zh) | 2009-09-02 |
KR20150080643A (ko) | 2015-07-09 |
HK1129836A1 (zh) | 2009-12-11 |
KR101617464B1 (ko) | 2016-05-02 |
AU2007305595A1 (en) | 2008-04-17 |
WO2008044611A1 (en) | 2008-04-17 |
JP4874339B2 (ja) | 2012-02-15 |
US20100021497A1 (en) | 2010-01-28 |
CN103223163A (zh) | 2013-07-31 |
NZ574776A (en) | 2012-03-30 |
EP2075005A1 (en) | 2009-07-01 |
EP2075005B1 (en) | 2015-12-02 |
KR20090057442A (ko) | 2009-06-05 |
CA2664799C (en) | 2016-01-05 |
US8753646B2 (en) | 2014-06-17 |
AU2007305595C1 (en) | 2014-10-02 |
EP2075005A4 (en) | 2010-09-01 |
CA2664799A1 (en) | 2008-04-17 |
AU2007305595B2 (en) | 2012-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0607088D0 (en) | Vaccine | |
GB0717911D0 (en) | Vaccine | |
GB0616306D0 (en) | Vaccines | |
GB0700135D0 (en) | Vaccine | |
GB0711858D0 (en) | Vaccine | |
HK1129836A1 (zh) | 疫苗 | |
GB0710538D0 (en) | Vaccine | |
GB0614460D0 (en) | Vaccines | |
ZA200901592B (en) | Vaccine | |
GB0625593D0 (en) | Vaccine | |
GB0709373D0 (en) | BCG-based anti-atheroma vaccine | |
GB0619824D0 (en) | Vaccine | |
GB0619820D0 (en) | Vaccine | |
GB0619826D0 (en) | Vaccine | |
GB0620815D0 (en) | Vaccine | |
GB0620816D0 (en) | vaccine | |
GB0620336D0 (en) | Vaccine | |
GB0619822D0 (en) | Vaccine | |
GB0619821D0 (en) | Vaccine | |
GB0614476D0 (en) | Vaccine | |
GB0614254D0 (en) | Vaccine | |
GB0608962D0 (en) | Vaccine | |
GB0606256D0 (en) | Anti-atheroma vaccine | |
GB0620337D0 (en) | Vaccine | |
GB0607087D0 (en) | Vaccine |